Copyright Reports & Markets. All rights reserved.

Global Immune Cell Banking Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Immune Cell Banking Service
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Immune Cell Banking Service by Type
    • 1.3.1 Overview: Global Immune Cell Banking Service Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Immune Cell Banking Service Consumption Value Market Share by Type in 2022
    • 1.3.3 Neonatal Immune Cell Storage
    • 1.3.4 Adult Immune Cell Storage
  • 1.4 Global Immune Cell Banking Service Market by Application
    • 1.4.1 Overview: Global Immune Cell Banking Service Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Medical Scene
    • 1.4.3 Non-medical Scene
  • 1.5 Global Immune Cell Banking Service Market Size & Forecast
  • 1.6 Global Immune Cell Banking Service Market Size and Forecast by Region
    • 1.6.1 Global Immune Cell Banking Service Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Immune Cell Banking Service Market Size by Region, (2018-2029)
    • 1.6.3 North America Immune Cell Banking Service Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Immune Cell Banking Service Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Immune Cell Banking Service Market Size and Prospect (2018-2029)
    • 1.6.6 South America Immune Cell Banking Service Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Immune Cell Banking Service Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 HealthBanks
    • 2.1.1 HealthBanks Details
    • 2.1.2 HealthBanks Major Business
    • 2.1.3 HealthBanks Immune Cell Banking Service Product and Solutions
    • 2.1.4 HealthBanks Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 HealthBanks Recent Developments and Future Plans
  • 2.2 BioLife Solutions
    • 2.2.1 BioLife Solutions Details
    • 2.2.2 BioLife Solutions Major Business
    • 2.2.3 BioLife Solutions Immune Cell Banking Service Product and Solutions
    • 2.2.4 BioLife Solutions Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 BioLife Solutions Recent Developments and Future Plans
  • 2.3 Sartorius
    • 2.3.1 Sartorius Details
    • 2.3.2 Sartorius Major Business
    • 2.3.3 Sartorius Immune Cell Banking Service Product and Solutions
    • 2.3.4 Sartorius Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Sartorius Recent Developments and Future Plans
  • 2.4 ThermoGenesis
    • 2.4.1 ThermoGenesis Details
    • 2.4.2 ThermoGenesis Major Business
    • 2.4.3 ThermoGenesis Immune Cell Banking Service Product and Solutions
    • 2.4.4 ThermoGenesis Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 ThermoGenesis Recent Developments and Future Plans
  • 2.5 Charles River
    • 2.5.1 Charles River Details
    • 2.5.2 Charles River Major Business
    • 2.5.3 Charles River Immune Cell Banking Service Product and Solutions
    • 2.5.4 Charles River Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Charles River Recent Developments and Future Plans
  • 2.6 Biorep Technologies
    • 2.6.1 Biorep Technologies Details
    • 2.6.2 Biorep Technologies Major Business
    • 2.6.3 Biorep Technologies Immune Cell Banking Service Product and Solutions
    • 2.6.4 Biorep Technologies Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Biorep Technologies Recent Developments and Future Plans
  • 2.7 Cryo-Cell International
    • 2.7.1 Cryo-Cell International Details
    • 2.7.2 Cryo-Cell International Major Business
    • 2.7.3 Cryo-Cell International Immune Cell Banking Service Product and Solutions
    • 2.7.4 Cryo-Cell International Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Cryo-Cell International Recent Developments and Future Plans
  • 2.8 CGT GLOBAL
    • 2.8.1 CGT GLOBAL Details
    • 2.8.2 CGT GLOBAL Major Business
    • 2.8.3 CGT GLOBAL Immune Cell Banking Service Product and Solutions
    • 2.8.4 CGT GLOBAL Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 CGT GLOBAL Recent Developments and Future Plans
  • 2.9 Cordlife Group
    • 2.9.1 Cordlife Group Details
    • 2.9.2 Cordlife Group Major Business
    • 2.9.3 Cordlife Group Immune Cell Banking Service Product and Solutions
    • 2.9.4 Cordlife Group Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Cordlife Group Recent Developments and Future Plans
  • 2.10 Celularity
    • 2.10.1 Celularity Details
    • 2.10.2 Celularity Major Business
    • 2.10.3 Celularity Immune Cell Banking Service Product and Solutions
    • 2.10.4 Celularity Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Celularity Recent Developments and Future Plans
  • 2.11 Boyalife
    • 2.11.1 Boyalife Details
    • 2.11.2 Boyalife Major Business
    • 2.11.3 Boyalife Immune Cell Banking Service Product and Solutions
    • 2.11.4 Boyalife Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Boyalife Recent Developments and Future Plans
  • 2.12 Beike Biotechnology
    • 2.12.1 Beike Biotechnology Details
    • 2.12.2 Beike Biotechnology Major Business
    • 2.12.3 Beike Biotechnology Immune Cell Banking Service Product and Solutions
    • 2.12.4 Beike Biotechnology Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Beike Biotechnology Recent Developments and Future Plans
  • 2.13 Forever Labs
    • 2.13.1 Forever Labs Details
    • 2.13.2 Forever Labs Major Business
    • 2.13.3 Forever Labs Immune Cell Banking Service Product and Solutions
    • 2.13.4 Forever Labs Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Forever Labs Recent Developments and Future Plans
  • 2.14 Redermis
    • 2.14.1 Redermis Details
    • 2.14.2 Redermis Major Business
    • 2.14.3 Redermis Immune Cell Banking Service Product and Solutions
    • 2.14.4 Redermis Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Redermis Recent Developments and Future Plans
  • 2.15 LifeCell International
    • 2.15.1 LifeCell International Details
    • 2.15.2 LifeCell International Major Business
    • 2.15.3 LifeCell International Immune Cell Banking Service Product and Solutions
    • 2.15.4 LifeCell International Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 LifeCell International Recent Developments and Future Plans
  • 2.16 VCANBIO
    • 2.16.1 VCANBIO Details
    • 2.16.2 VCANBIO Major Business
    • 2.16.3 VCANBIO Immune Cell Banking Service Product and Solutions
    • 2.16.4 VCANBIO Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 VCANBIO Recent Developments and Future Plans
  • 2.17 BGI Group
    • 2.17.1 BGI Group Details
    • 2.17.2 BGI Group Major Business
    • 2.17.3 BGI Group Immune Cell Banking Service Product and Solutions
    • 2.17.4 BGI Group Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 BGI Group Recent Developments and Future Plans
  • 2.18 Shanghai Cell Therapy Group
    • 2.18.1 Shanghai Cell Therapy Group Details
    • 2.18.2 Shanghai Cell Therapy Group Major Business
    • 2.18.3 Shanghai Cell Therapy Group Immune Cell Banking Service Product and Solutions
    • 2.18.4 Shanghai Cell Therapy Group Immune Cell Banking Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Shanghai Cell Therapy Group Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Immune Cell Banking Service Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Immune Cell Banking Service by Company Revenue
    • 3.2.2 Top 3 Immune Cell Banking Service Players Market Share in 2022
    • 3.2.3 Top 6 Immune Cell Banking Service Players Market Share in 2022
  • 3.3 Immune Cell Banking Service Market: Overall Company Footprint Analysis
    • 3.3.1 Immune Cell Banking Service Market: Region Footprint
    • 3.3.2 Immune Cell Banking Service Market: Company Product Type Footprint
    • 3.3.3 Immune Cell Banking Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Immune Cell Banking Service Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Immune Cell Banking Service Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Immune Cell Banking Service Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Immune Cell Banking Service Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Immune Cell Banking Service Consumption Value by Type (2018-2029)
  • 6.2 North America Immune Cell Banking Service Consumption Value by Application (2018-2029)
  • 6.3 North America Immune Cell Banking Service Market Size by Country
    • 6.3.1 North America Immune Cell Banking Service Consumption Value by Country (2018-2029)
    • 6.3.2 United States Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Immune Cell Banking Service Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Immune Cell Banking Service Consumption Value by Type (2018-2029)
  • 7.2 Europe Immune Cell Banking Service Consumption Value by Application (2018-2029)
  • 7.3 Europe Immune Cell Banking Service Market Size by Country
    • 7.3.1 Europe Immune Cell Banking Service Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 7.3.3 France Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Immune Cell Banking Service Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Immune Cell Banking Service Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Immune Cell Banking Service Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Immune Cell Banking Service Market Size by Region
    • 8.3.1 Asia-Pacific Immune Cell Banking Service Consumption Value by Region (2018-2029)
    • 8.3.2 China Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 8.3.5 India Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Immune Cell Banking Service Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Immune Cell Banking Service Consumption Value by Type (2018-2029)
  • 9.2 South America Immune Cell Banking Service Consumption Value by Application (2018-2029)
  • 9.3 South America Immune Cell Banking Service Market Size by Country
    • 9.3.1 South America Immune Cell Banking Service Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Immune Cell Banking Service Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Immune Cell Banking Service Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Immune Cell Banking Service Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Immune Cell Banking Service Market Size by Country
    • 10.3.1 Middle East & Africa Immune Cell Banking Service Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Immune Cell Banking Service Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Immune Cell Banking Service Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Immune Cell Banking Service Market Drivers
  • 11.2 Immune Cell Banking Service Market Restraints
  • 11.3 Immune Cell Banking Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Immune Cell Banking Service Industry Chain
  • 12.2 Immune Cell Banking Service Upstream Analysis
  • 12.3 Immune Cell Banking Service Midstream Analysis
  • 12.4 Immune Cell Banking Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Immune Cell Banking Service market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    The immune cell storage business refers to the use of biotechnology to extract a certain number of healthy immune cells from the human body and store them in cryogenic liquid nitrogen tanks at -150°C to -196°C to maintain the activity and function of immune cells for a long time. , in order to resuscitate and reinfuse the patient when clinically necessary to treat the disease.
    The Global Info Research report includes an overview of the development of the Immune Cell Banking Service industry chain, the market status of Medical Scene (Neonatal Immune Cell Storage, Adult Immune Cell Storage), Non-medical Scene (Neonatal Immune Cell Storage, Adult Immune Cell Storage), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immune Cell Banking Service.
    Regionally, the report analyzes the Immune Cell Banking Service markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immune Cell Banking Service market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Immune Cell Banking Service market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immune Cell Banking Service industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Neonatal Immune Cell Storage, Adult Immune Cell Storage).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immune Cell Banking Service market.
    Regional Analysis: The report involves examining the Immune Cell Banking Service market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immune Cell Banking Service market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Immune Cell Banking Service:
    Company Analysis: Report covers individual Immune Cell Banking Service players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immune Cell Banking Service This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Medical Scene, Non-medical Scene).
    Technology Analysis: Report covers specific technologies relevant to Immune Cell Banking Service. It assesses the current state, advancements, and potential future developments in Immune Cell Banking Service areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immune Cell Banking Service market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Immune Cell Banking Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Neonatal Immune Cell Storage
    Adult Immune Cell Storage
    Market segment by Application
    Medical Scene
    Non-medical Scene
    Market segment by players, this report covers
    HealthBanks
    BioLife Solutions
    Sartorius
    ThermoGenesis
    Charles River
    Biorep Technologies
    Cryo-Cell International
    CGT GLOBAL
    Cordlife Group
    Celularity
    Boyalife
    Beike Biotechnology
    Forever Labs
    Redermis
    LifeCell International
    VCANBIO
    BGI Group
    Shanghai Cell Therapy Group
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Immune Cell Banking Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Immune Cell Banking Service, with revenue, gross margin and global market share of Immune Cell Banking Service from 2018 to 2023.
    Chapter 3, the Immune Cell Banking Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Immune Cell Banking Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Immune Cell Banking Service.
    Chapter 13, to describe Immune Cell Banking Service research findings and conclusion.

    Buy now